renin was identified in seven cases of metastatic tumour within the kidney, but immunoreactive renin was present in two out of seven metastatic renal cell carcinomas in other organs. None of the subjects had clinical, biochemical or histological evidence of excess renin secretion. We suggest that renal cell carcinoma may commonly secrete renin and that the hormone may be biologically inactive.
It is now well known that malignant tumours can secrete many hormones. ' Renal cell carcinomas have been shown to be associated with a growing list of secretory products.' There are three isolated case reports of secretion of renin by a renal cell carcinoma.-5 We have studied one of these cases and successfully stained the renin-containing cells within the tumour with an antibody to pure human renin and the peroxidase-antiperoxidase (PAP) method. 6 The renin secreted by this tumour was mainly biologically inactive.5 Since the presence in the plasma of a biologically inactive hormone may not be clinically apparent,' renal cell carcinoma may secrete renin more often that is realised. To investigate this possibility, we have examined a series of renal cell carcinomas using the renin antiserum and the PAP technique. We report here the immunocytochemical study of primary and metastatic renal tumours and of secondary tumours within the renal cortex.
Material and methods
To obtain optimally fixed material we confined our study to surgically excised tumours. These represent an unselected consecutive series of renal tumours from the files of the Pathology Department, Western Infirmary, Glasgow.
All tissue was fixed in 10% neutral buffered formalin and embedded in paraffin wax. From each case we selected two blocks which contained both Accepted for publication 12 October 1983 tumour and a piece of adjacent kidney in which the renin-containing juxtaglomerular cells provided a known positive staining reaction. Sections (4 urm) were cut for routine histological stains and adjacent sections used for immunocytochemistry.
IMMUNOCYTOCHEMISTRY

Renin antibody
The antibody to human renin was raised in rabbits from human renin completely purified from a juxtaglomerular cell tumour. The rabbit antiserum has been tested for in vitro specificity7 and its use in staining renin with the PAP technique in the normal and pathological human kidney has been published.8 I We have found it to reliably stain renin in paraffin and Araldite-embedded tissue examined both by light and electron microscopy. 6 '0 
Results
IMMUNOCYTOCHEMISTRY
The PAP preparations always showed stainable renin in the juxtaglomerular apparatus. Indeed, the compressed kidney adjacent to the tumour often showed hyperplasia of the renin-containing juxtaglomerular cells ( Fig. 1 ).
Primary renal cell carcinoma In this unselected consecutive series of renal cell carcinomas, we found that seven of 19 tumours contained immunoreactive renin. The histological typing of these tumours is shown in Table 1 . The majority of the tumours which contained immunostainable renin were clear cell carcinomas. In five of the seven tumours the cells containing immunoreactive renin Lindop, Fleming were small perivascular cells located immediately external to the endothelium of the blood vessels in the tumour (Figs. 2, 3 and 4) . These cells were sometimes very scanty in number and usually present singly. They were constant in position but variable in morphology. Their nuclei were most commonly flattened, sometimes notched, and usually smaller than the cells which were clearly tumour cells. They had inconspicuous nucleoli and when closely applied to a blood vessel, the cells often had long cytoplasmic processes containing PAP-positive granules (Fig. 4) .
When the cells were in stroma and apparently not compressed by surrounding tumour cells they were sometimes larger. They occasionally approached the tumour cells in size (Fig. 2) and their nucleus was often as large (Fig. 3) . These renin-containing cells did not resemble the normal juxtaglomerular apparatus granular cells, nor could it be established by histology whether or not they were neoplastic cells. There was no histological or immunocytochemical evidence that they were macrophages.
In two cases, one a clear cell carcinoma and the other a more granular cell variant, cells which had the histological appearance of tumour cells contained granular deposits of immunoreactive renin (Fig. 5 ). These cells were indistinguishable from the other tumour cells and were present focally throughout the tumour. The clear cell carcinoma also contained occasional perivascular cells which contained immunostainable renin as described above. These Lindop, Fleming granules could be identified3 and one was a typical clear cell carcinoma in which the tumour cells contained granules whose ultrastructural appearance was typical of renin granules.4 The third case (which we have studied),6 showed immunostainable renin in small perivascular granular cells in a clear cell carcinoma, the tumour cells being uniformly negative. In this present study we have detected immunostainable renin in seven of 19 primary renal cell carcinomas and in five of these cases the cells containing immunostainable renin were morphologically similar and had the same perivascular distribution as our previously reported case. 6 Renin in cells within a tumour could either have been taken up from the plasma or synthesised by the cells.
The positive cells contained granules and in the single case which we have previously studied by immunocytochemistry and electron microscopy, there was strong clinical' and morphological evidence that these perivascular cells in the tumour were secreting renin. suppress physiological renin secretion in the kidney) or that any renin secreted was biologically inactive. The case which we have already reported& showed hyperplasia of the renin containing cells of the juxtaglomerular apparatus in the adjacent kidney. The renin secreted by this tumour was mainly biologically inactive, had a higher molecular weight, and was possibly a prohormone.
The antibody used in this study binds to both active and inactive renin in vitro,6 " therefore the nature of the renin which we have shown to be present in renal cell carcinoma remains uncertain and will have to be studied biochemically. This is at present underway; however, it is well known that in other situations tumours may secrete biologically inactive hormones. ' Thus we suggest that while secretion of active renin by renal cell carcinoma appears to be rare, our preliminary study indicates that secretion of inactive renin may be common.
